Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease
- PMID: 3086422
- DOI: 10.1007/BF03348085
Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease
Abstract
To investigate the interrelationships between body weight and gonadotropin secretion of polycystic ovarian disease (PCO), basal hormonal pattern and responses of gonadotropins and 17 beta estradiol (E2) to 25 micrograms (bolus) and 175 micrograms (4-h infusion) of synthetic luteinizing hormone-releasing hormone (LHRH) were studied in two age-matched groups of 18 obese (OB-PCO) and 18 normal-weight (NO-PCO) women suffering from the syndrome. Unlike other hormone levels, plasma LH and the LH/FSH ratio values were significantly higher (p less than 0.001) in NO-PCO than in OB-PCO females. Moreover, LH response to both stimuli was significantly greater in NO-PCO with respect to OB-PCO. No differences were found in FSH response, whereas E2 response was significantly higher (p less than 0.05) in the NO-PCO group during the continuous infusion test. These results emphasize the role of body weight in the development of PCO in obese females.
Similar articles
-
The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.J Clin Endocrinol Metab. 1988 Jan;66(1):131-9. doi: 10.1210/jcem-66-1-131. J Clin Endocrinol Metab. 1988. PMID: 2961783
-
Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.J Clin Endocrinol Metab. 1989 Jun;68(6):1111-7. doi: 10.1210/jcem-68-6-1111. J Clin Endocrinol Metab. 1989. PMID: 2524501
-
Pituitary-ovarian relationships in polycystic ovary syndrome.J Clin Endocrinol Metab. 1977 Oct;45(4):798-801. doi: 10.1210/jcem-45-4-798. J Clin Endocrinol Metab. 1977. PMID: 334789
-
Can polycystic ovary syndrome exist without concomitant hypothalamic dysfunction?Semin Reprod Endocrinol. 1997 May;15(2):169-75. doi: 10.1055/s-2007-1016298. Semin Reprod Endocrinol. 1997. PMID: 9165660 Review.
-
Adrenal disorders and polycystic ovary syndrome.Horm Res. 1992;37 Suppl 3:39-44. doi: 10.1159/000182399. Horm Res. 1992. PMID: 1427640 Review.
Cited by
-
Functional significance of the innervation of the gonads.Endocrine. 2005 Dec;28(3):309-18. doi: 10.1385/ENDO:28:3:309. Endocrine. 2005. PMID: 16388121 Review.
-
Hyperandrogenism, hyperinsulinism and polycystic ovarian disease.J Endocrinol Invest. 1986 Dec;9(6):531-3. doi: 10.1007/BF03346983. J Endocrinol Invest. 1986. PMID: 3571857 No abstract available.
-
Insulin as a factor of increased androgen production in women with obesity and polycystic ovaries.J Endocrinol Invest. 1987 Dec;10(6):575-9. doi: 10.1007/BF03346997. J Endocrinol Invest. 1987. PMID: 3326891
-
Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome.J Endocrinol Invest. 1998 Oct;21(9):602-11. doi: 10.1007/BF03350785. J Endocrinol Invest. 1998. PMID: 9856414 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous